1. Home
  2. IPHA vs NMP Comparison

IPHA vs NMP Comparison

Compare IPHA & NMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • NMP
  • Stock Information
  • Founded
  • IPHA 1999
  • NMP 2024
  • Country
  • IPHA France
  • NMP United States
  • Employees
  • IPHA N/A
  • NMP N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • NMP Blank Checks
  • Sector
  • IPHA Health Care
  • NMP Finance
  • Exchange
  • IPHA Nasdaq
  • NMP Nasdaq
  • Market Cap
  • IPHA 160.1M
  • NMP 158.4M
  • IPO Year
  • IPHA 2019
  • NMP 2025
  • Fundamental
  • Price
  • IPHA $1.95
  • NMP $9.97
  • Analyst Decision
  • IPHA Hold
  • NMP
  • Analyst Count
  • IPHA 2
  • NMP 0
  • Target Price
  • IPHA $2.00
  • NMP N/A
  • AVG Volume (30 Days)
  • IPHA 21.4K
  • NMP 87.3K
  • Earning Date
  • IPHA 09-17-2025
  • NMP 01-01-0001
  • Dividend Yield
  • IPHA N/A
  • NMP N/A
  • EPS Growth
  • IPHA N/A
  • NMP N/A
  • EPS
  • IPHA N/A
  • NMP N/A
  • Revenue
  • IPHA $14,839,695.00
  • NMP N/A
  • Revenue This Year
  • IPHA $350.96
  • NMP N/A
  • Revenue Next Year
  • IPHA $32.92
  • NMP N/A
  • P/E Ratio
  • IPHA N/A
  • NMP N/A
  • Revenue Growth
  • IPHA N/A
  • NMP N/A
  • 52 Week Low
  • IPHA $1.29
  • NMP $9.90
  • 52 Week High
  • IPHA $3.51
  • NMP $9.99
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 50.85
  • NMP N/A
  • Support Level
  • IPHA $1.95
  • NMP N/A
  • Resistance Level
  • IPHA $2.10
  • NMP N/A
  • Average True Range (ATR)
  • IPHA 0.07
  • NMP 0.00
  • MACD
  • IPHA 0.02
  • NMP 0.00
  • Stochastic Oscillator
  • IPHA 66.09
  • NMP 0.00

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About NMP NMP Acquisition Corp. Class A Ordinary Shares

NMP Acquisition Corp is a blank check company.

Share on Social Networks: